nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1A1—liver cancer	0.313	1	CbGaD
Omeprazole—ABCC3—Doxorubicin—liver cancer	0.0796	0.194	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—liver cancer	0.0688	0.168	CbGbCtD
Omeprazole—ABCG2—Sorafenib—liver cancer	0.0539	0.132	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—liver cancer	0.0327	0.0799	CbGbCtD
Omeprazole—CYP2C8—Sorafenib—liver cancer	0.0287	0.0701	CbGbCtD
Omeprazole—CYP2C19—Sorafenib—liver cancer	0.0241	0.0588	CbGbCtD
Omeprazole—CYP1A2—Sorafenib—liver cancer	0.0222	0.0543	CbGbCtD
Omeprazole—CYP2C9—Sorafenib—liver cancer	0.02	0.0489	CbGbCtD
Omeprazole—ABCB1—Sorafenib—liver cancer	0.0194	0.0475	CbGbCtD
Omeprazole—CYP2D6—Sorafenib—liver cancer	0.0183	0.0447	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—liver cancer	0.0118	0.0288	CbGbCtD
Omeprazole—CYP3A4—Sorafenib—liver cancer	0.0116	0.0284	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—liver cancer	0.0111	0.0271	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—liver cancer	0.00706	0.0173	CbGbCtD
Omeprazole—ABCC3—bile duct—liver cancer	0.00483	0.463	CbGeAlD
Omeprazole—ATP4B—liver—liver cancer	0.00136	0.131	CbGeAlD
Omeprazole—ABCC3—gall bladder—liver cancer	0.00103	0.0988	CbGeAlD
Omeprazole—Rabeprazole—CYP1A1—liver cancer	0.000919	0.573	CrCbGaD
Omeprazole—Lansoprazole—CYP1A1—liver cancer	0.000685	0.427	CrCbGaD
Omeprazole—ATP4A—liver—liver cancer	0.000594	0.057	CbGeAlD
Omeprazole—CYP2C18—liver—liver cancer	0.000488	0.0468	CbGeAlD
Omeprazole—ABCC3—liver—liver cancer	0.000302	0.029	CbGeAlD
Omeprazole—CYP1B1—liver—liver cancer	0.000236	0.0227	CbGeAlD
Omeprazole—Purpura—Doxorubicin—liver cancer	0.000218	0.00154	CcSEcCtD
Omeprazole—Asthenia—Sorafenib—liver cancer	0.000216	0.00153	CcSEcCtD
Omeprazole—Hypoglycaemia—Doxorubicin—liver cancer	0.000215	0.00152	CcSEcCtD
Omeprazole—Pruritus—Sorafenib—liver cancer	0.000213	0.00151	CcSEcCtD
Omeprazole—Blood creatinine increased—Epirubicin—liver cancer	0.000212	0.0015	CcSEcCtD
Omeprazole—Hyponatraemia—Doxorubicin—liver cancer	0.000211	0.00149	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00021	0.00149	CcSEcCtD
Omeprazole—Pain in extremity—Doxorubicin—liver cancer	0.00021	0.00149	CcSEcCtD
Omeprazole—Osteoarthritis—Doxorubicin—liver cancer	0.00021	0.00149	CcSEcCtD
Omeprazole—Diplopia—Doxorubicin—liver cancer	0.00021	0.00149	CcSEcCtD
Omeprazole—Dry skin—Epirubicin—liver cancer	0.000208	0.00147	CcSEcCtD
Omeprazole—CYP2C19—liver—liver cancer	0.000208	0.0199	CbGeAlD
Omeprazole—Abdominal pain upper—Epirubicin—liver cancer	0.000207	0.00147	CcSEcCtD
Omeprazole—Migraine—Doxorubicin—liver cancer	0.000206	0.00146	CcSEcCtD
Omeprazole—Hypokalaemia—Epirubicin—liver cancer	0.000206	0.00146	CcSEcCtD
Omeprazole—Diarrhoea—Sorafenib—liver cancer	0.000206	0.00146	CcSEcCtD
Omeprazole—Breast disorder—Epirubicin—liver cancer	0.000205	0.00145	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000204	0.00145	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000204	0.00145	CcSEcCtD
Omeprazole—Face oedema—Doxorubicin—liver cancer	0.000202	0.00143	CcSEcCtD
Omeprazole—Gastritis—Epirubicin—liver cancer	0.000201	0.00142	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.0002	0.00142	CcSEcCtD
Omeprazole—Muscular weakness—Epirubicin—liver cancer	0.0002	0.00142	CcSEcCtD
Omeprazole—Dizziness—Sorafenib—liver cancer	0.000199	0.00141	CcSEcCtD
Omeprazole—Abdominal distension—Epirubicin—liver cancer	0.000197	0.0014	CcSEcCtD
Omeprazole—Blood creatinine increased—Doxorubicin—liver cancer	0.000196	0.00139	CcSEcCtD
Omeprazole—Dysphagia—Epirubicin—liver cancer	0.000196	0.00139	CcSEcCtD
Omeprazole—Influenza—Epirubicin—liver cancer	0.000196	0.00139	CcSEcCtD
Omeprazole—Asthma—Epirubicin—liver cancer	0.000196	0.00139	CcSEcCtD
Omeprazole—Dry skin—Doxorubicin—liver cancer	0.000192	0.00136	CcSEcCtD
Omeprazole—Pancreatitis—Epirubicin—liver cancer	0.000192	0.00136	CcSEcCtD
Omeprazole—Vomiting—Sorafenib—liver cancer	0.000192	0.00136	CcSEcCtD
Omeprazole—Abdominal pain upper—Doxorubicin—liver cancer	0.000192	0.00136	CcSEcCtD
Omeprazole—Hypokalaemia—Doxorubicin—liver cancer	0.000191	0.00135	CcSEcCtD
Omeprazole—Angina pectoris—Epirubicin—liver cancer	0.000191	0.00135	CcSEcCtD
Omeprazole—Rash—Sorafenib—liver cancer	0.00019	0.00135	CcSEcCtD
Omeprazole—Dermatitis—Sorafenib—liver cancer	0.00019	0.00134	CcSEcCtD
Omeprazole—Breast disorder—Doxorubicin—liver cancer	0.00019	0.00134	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000189	0.00134	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000189	0.00134	CcSEcCtD
Omeprazole—Headache—Sorafenib—liver cancer	0.000189	0.00134	CcSEcCtD
Omeprazole—ABCB1—embryo—liver cancer	0.000188	0.018	CbGeAlD
Omeprazole—Pancytopenia—Epirubicin—liver cancer	0.000186	0.00132	CcSEcCtD
Omeprazole—Gastritis—Doxorubicin—liver cancer	0.000186	0.00131	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000185	0.00131	CcSEcCtD
Omeprazole—Muscular weakness—Doxorubicin—liver cancer	0.000185	0.00131	CcSEcCtD
Omeprazole—Neutropenia—Epirubicin—liver cancer	0.000183	0.0013	CcSEcCtD
Omeprazole—Dysuria—Epirubicin—liver cancer	0.000183	0.0013	CcSEcCtD
Omeprazole—Abdominal distension—Doxorubicin—liver cancer	0.000182	0.00129	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Epirubicin—liver cancer	0.000182	0.00129	CcSEcCtD
Omeprazole—Dysphagia—Doxorubicin—liver cancer	0.000181	0.00128	CcSEcCtD
Omeprazole—Asthma—Doxorubicin—liver cancer	0.000181	0.00128	CcSEcCtD
Omeprazole—Influenza—Doxorubicin—liver cancer	0.000181	0.00128	CcSEcCtD
Omeprazole—CYP2C8—liver—liver cancer	0.000181	0.0174	CbGeAlD
Omeprazole—Pollakiuria—Epirubicin—liver cancer	0.000181	0.00128	CcSEcCtD
Omeprazole—Nausea—Sorafenib—liver cancer	0.000179	0.00127	CcSEcCtD
Omeprazole—Photosensitivity reaction—Epirubicin—liver cancer	0.000179	0.00127	CcSEcCtD
Omeprazole—Weight increased—Epirubicin—liver cancer	0.000178	0.00126	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—liver cancer	0.000178	0.00126	CcSEcCtD
Omeprazole—Weight decreased—Epirubicin—liver cancer	0.000177	0.00126	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—liver cancer	0.000177	0.00125	CcSEcCtD
Omeprazole—ABCG2—liver—liver cancer	0.000176	0.0169	CbGeAlD
Omeprazole—Infestation NOS—Epirubicin—liver cancer	0.000175	0.00124	CcSEcCtD
Omeprazole—Infestation—Epirubicin—liver cancer	0.000175	0.00124	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000173	0.00123	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—liver cancer	0.000172	0.00122	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—liver cancer	0.000172	0.00122	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—liver cancer	0.00017	0.00121	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—liver cancer	0.00017	0.00121	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—liver cancer	0.00017	0.0012	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—liver cancer	0.00017	0.0012	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—liver cancer	0.000169	0.0012	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—liver cancer	0.000169	0.0012	CcSEcCtD
Omeprazole—CYP1A2—liver—liver cancer	0.000169	0.0162	CbGeAlD
Omeprazole—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000168	0.00119	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—liver cancer	0.000167	0.00119	CcSEcCtD
Omeprazole—CYP1A1—liver—liver cancer	0.000167	0.016	CbGeAlD
Omeprazole—Haematuria—Epirubicin—liver cancer	0.000167	0.00118	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—liver cancer	0.000165	0.00117	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—liver cancer	0.000165	0.00117	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—liver cancer	0.000165	0.00117	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—liver cancer	0.000165	0.00117	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—liver cancer	0.000164	0.00116	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—liver cancer	0.000164	0.00116	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—liver cancer	0.000163	0.00115	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—liver cancer	0.000162	0.00114	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—liver cancer	0.000162	0.00114	CcSEcCtD
Omeprazole—CYP2C9—liver—liver cancer	0.000161	0.0154	CbGeAlD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00016	0.00113	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—liver cancer	0.00016	0.00113	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—liver cancer	0.000159	0.00113	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—liver cancer	0.000158	0.00112	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—liver cancer	0.000158	0.00112	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—liver cancer	0.000157	0.00111	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—liver cancer	0.000157	0.00111	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—liver cancer	0.000157	0.00111	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—liver cancer	0.000157	0.00111	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—liver cancer	0.000156	0.00111	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—liver cancer	0.000156	0.0011	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—liver cancer	0.000155	0.0011	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—liver cancer	0.000154	0.00109	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—liver cancer	0.000154	0.00109	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—liver cancer	0.000154	0.00109	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—liver cancer	0.000154	0.00109	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000153	0.00108	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—liver cancer	0.000152	0.00108	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—liver cancer	0.000152	0.00107	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—liver cancer	0.000151	0.00107	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—liver cancer	0.000151	0.00107	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—liver cancer	0.000148	0.00105	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—liver cancer	0.000148	0.00105	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—liver cancer	0.000147	0.00104	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—liver cancer	0.000146	0.00104	CcSEcCtD
Omeprazole—Flushing—Epirubicin—liver cancer	0.000146	0.00103	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—liver cancer	0.000145	0.00103	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—liver cancer	0.000145	0.00103	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—liver cancer	0.000144	0.00102	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—liver cancer	0.000144	0.00102	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000143	0.00101	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—liver cancer	0.000143	0.00101	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—liver cancer	0.000143	0.00101	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—liver cancer	0.000142	0.00101	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—liver cancer	0.000142	0.001	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—liver cancer	0.000141	0.001	CcSEcCtD
Omeprazole—Chills—Epirubicin—liver cancer	0.000141	0.000997	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—liver cancer	0.00014	0.00099	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—liver cancer	0.000139	0.000981	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—liver cancer	0.000137	0.000973	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—liver cancer	0.000137	0.000972	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—liver cancer	0.000137	0.000967	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—liver cancer	0.000136	0.00096	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—liver cancer	0.000135	0.000958	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—liver cancer	0.000135	0.000954	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—liver cancer	0.000135	0.000953	CcSEcCtD
Omeprazole—Tension—Epirubicin—liver cancer	0.000134	0.000949	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—liver cancer	0.000134	0.000947	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—liver cancer	0.000133	0.000939	CcSEcCtD
Omeprazole—Back pain—Epirubicin—liver cancer	0.000132	0.000935	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—liver cancer	0.000131	0.00093	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—liver cancer	0.000131	0.000928	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—liver cancer	0.000131	0.000926	CcSEcCtD
Omeprazole—Chills—Doxorubicin—liver cancer	0.00013	0.000922	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—liver cancer	0.000129	0.000911	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—liver cancer	0.000128	0.000908	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—liver cancer	0.000127	0.0009	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—liver cancer	0.000127	0.000897	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—liver cancer	0.000126	0.000895	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—liver cancer	0.000126	0.000894	CcSEcCtD
Omeprazole—Agitation—Epirubicin—liver cancer	0.000125	0.000888	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—liver cancer	0.000124	0.000882	CcSEcCtD
Omeprazole—Tension—Doxorubicin—liver cancer	0.000124	0.000878	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—liver cancer	0.000124	0.000876	CcSEcCtD
Omeprazole—Malaise—Epirubicin—liver cancer	0.000123	0.000872	CcSEcCtD
Omeprazole—CYP3A4—liver—liver cancer	0.000123	0.0118	CbGeAlD
Omeprazole—Nervousness—Doxorubicin—liver cancer	0.000123	0.000869	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—liver cancer	0.000123	0.000869	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—liver cancer	0.000122	0.000865	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—liver cancer	0.000122	0.000865	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—liver cancer	0.000121	0.00086	CcSEcCtD
Omeprazole—CYP2D6—liver—liver cancer	0.000121	0.0116	CbGeAlD
Omeprazole—Palpitations—Epirubicin—liver cancer	0.000121	0.000854	CcSEcCtD
Omeprazole—Cough—Epirubicin—liver cancer	0.000119	0.000844	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—liver cancer	0.000119	0.000843	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—liver cancer	0.000118	0.000835	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—liver cancer	0.000117	0.00083	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—liver cancer	0.000117	0.000827	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—liver cancer	0.000116	0.000823	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—liver cancer	0.000116	0.000823	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—liver cancer	0.000116	0.000823	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—liver cancer	0.000116	0.000822	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—liver cancer	0.000116	0.00082	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000115	0.000817	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—liver cancer	0.000115	0.000813	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—liver cancer	0.000114	0.000807	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—liver cancer	0.000114	0.000805	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—liver cancer	0.000113	0.000804	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—liver cancer	0.000113	0.000801	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—liver cancer	0.000112	0.000796	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—liver cancer	0.000112	0.000791	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—liver cancer	0.000111	0.000789	CcSEcCtD
Omeprazole—Infection—Epirubicin—liver cancer	0.000111	0.000784	CcSEcCtD
Omeprazole—Cough—Doxorubicin—liver cancer	0.00011	0.000781	CcSEcCtD
Omeprazole—Shock—Epirubicin—liver cancer	0.00011	0.000776	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—liver cancer	0.000109	0.000774	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—liver cancer	0.000109	0.000773	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—liver cancer	0.000109	0.000772	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—liver cancer	0.000109	0.00077	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—liver cancer	0.000108	0.000766	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—liver cancer	0.000108	0.000763	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—liver cancer	0.000108	0.000762	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—liver cancer	0.000108	0.000762	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—liver cancer	0.000108	0.000762	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—liver cancer	0.000107	0.000759	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000107	0.000756	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—liver cancer	0.000106	0.000752	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—liver cancer	0.000106	0.000752	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—liver cancer	0.000105	0.000745	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—liver cancer	0.000104	0.000736	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—liver cancer	0.000103	0.00073	CcSEcCtD
Omeprazole—Infection—Doxorubicin—liver cancer	0.000102	0.000725	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000101	0.000719	CcSEcCtD
Omeprazole—Shock—Doxorubicin—liver cancer	0.000101	0.000718	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—liver cancer	0.000101	0.000716	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000101	0.000715	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—liver cancer	0.000101	0.000714	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—liver cancer	0.000101	0.000713	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—liver cancer	0.0001	0.000709	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—liver cancer	0.0001	0.000709	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—liver cancer	9.96e-05	0.000706	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—liver cancer	9.93e-05	0.000703	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—liver cancer	9.9e-05	0.000701	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—liver cancer	9.83e-05	0.000696	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—liver cancer	9.81e-05	0.000695	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—liver cancer	9.68e-05	0.000686	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—liver cancer	9.62e-05	0.000681	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—liver cancer	9.6e-05	0.00068	CcSEcCtD
Omeprazole—Pain—Epirubicin—liver cancer	9.53e-05	0.000675	CcSEcCtD
Omeprazole—Constipation—Epirubicin—liver cancer	9.53e-05	0.000675	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.39e-05	0.000665	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—liver cancer	9.32e-05	0.00066	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—liver cancer	9.26e-05	0.000656	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—liver cancer	9.19e-05	0.000651	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—liver cancer	9.18e-05	0.00065	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—liver cancer	9.16e-05	0.000649	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—liver cancer	9.11e-05	0.000645	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—liver cancer	9.07e-05	0.000643	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—liver cancer	8.96e-05	0.000635	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—liver cancer	8.9e-05	0.00063	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—liver cancer	8.89e-05	0.000629	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—liver cancer	8.85e-05	0.000627	CcSEcCtD
Omeprazole—Pain—Doxorubicin—liver cancer	8.81e-05	0.000624	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—liver cancer	8.81e-05	0.000624	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—liver cancer	8.81e-05	0.000624	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—liver cancer	8.81e-05	0.000624	CcSEcCtD
Omeprazole—ABCB1—liver—liver cancer	8.68e-05	0.00833	CbGeAlD
Omeprazole—Feeling abnormal—Doxorubicin—liver cancer	8.49e-05	0.000602	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—liver cancer	8.43e-05	0.000597	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—liver cancer	8.21e-05	0.000581	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—liver cancer	8.19e-05	0.00058	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—liver cancer	8.15e-05	0.000577	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—liver cancer	8.15e-05	0.000577	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—liver cancer	7.99e-05	0.000566	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—liver cancer	7.88e-05	0.000558	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—liver cancer	7.62e-05	0.00054	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—liver cancer	7.59e-05	0.000538	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—liver cancer	7.4e-05	0.000524	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—liver cancer	7.37e-05	0.000522	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—liver cancer	7.29e-05	0.000517	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—liver cancer	7.08e-05	0.000502	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—liver cancer	7.05e-05	0.0005	CcSEcCtD
Omeprazole—Rash—Epirubicin—liver cancer	7.02e-05	0.000498	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—liver cancer	7.02e-05	0.000497	CcSEcCtD
Omeprazole—Headache—Epirubicin—liver cancer	6.98e-05	0.000494	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—liver cancer	6.82e-05	0.000483	CcSEcCtD
Omeprazole—Nausea—Epirubicin—liver cancer	6.62e-05	0.000469	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—liver cancer	6.55e-05	0.000464	CcSEcCtD
Omeprazole—Rash—Doxorubicin—liver cancer	6.5e-05	0.00046	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—liver cancer	6.49e-05	0.00046	CcSEcCtD
Omeprazole—Headache—Doxorubicin—liver cancer	6.46e-05	0.000457	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—liver cancer	6.12e-05	0.000434	CcSEcCtD
Omeprazole—CYP2D6—Metabolism—ALDOB—liver cancer	9.69e-06	7.81e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.64e-06	7.76e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDOB—liver cancer	9.61e-06	7.74e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CB—liver cancer	9.61e-06	7.74e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.6e-06	7.73e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PSMA4—liver cancer	9.57e-06	7.71e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PSMD10—liver cancer	9.57e-06	7.71e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	9.56e-06	7.7e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CD—liver cancer	9.54e-06	7.68e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MTHFR—liver cancer	9.52e-06	7.67e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—liver cancer	9.42e-06	7.59e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARA—liver cancer	9.34e-06	7.52e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GOT2—liver cancer	9.31e-06	7.5e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A1—liver cancer	9.29e-06	7.48e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CD—liver cancer	9.28e-06	7.47e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CRABP1—liver cancer	9.25e-06	7.45e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTA4—liver cancer	9.21e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CRABP1—liver cancer	9.17e-06	7.38e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—liver cancer	9.16e-06	7.38e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.05e-06	7.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.01e-06	7.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTA2—liver cancer	8.98e-06	7.23e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.92e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.8e-06	7.09e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HPGDS—liver cancer	8.79e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PSMA4—liver cancer	8.78e-06	7.07e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PSMD10—liver cancer	8.78e-06	7.07e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP2E1—liver cancer	8.76e-06	7.05e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.74e-06	7.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTA1—liver cancer	8.66e-06	6.98e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MTHFR—liver cancer	8.66e-06	6.98e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HPGDS—liver cancer	8.58e-06	6.91e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NAT2—liver cancer	8.57e-06	6.9e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GOT2—liver cancer	8.54e-06	6.88e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARA—liver cancer	8.5e-06	6.85e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.48e-06	6.83e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.39e-06	6.76e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CB—liver cancer	8.32e-06	6.7e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.25e-06	6.65e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.24e-06	6.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDOB—liver cancer	8.21e-06	6.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GLUL—liver cancer	8.2e-06	6.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CPT1B—liver cancer	8.2e-06	6.61e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYCS—liver cancer	8.19e-06	6.6e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CB—liver cancer	8.09e-06	6.51e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HPGDS—liver cancer	8.08e-06	6.51e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	8.07e-06	6.5e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GGT1—liver cancer	8.04e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GOT1—liver cancer	8.04e-06	6.47e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2E1—liver cancer	8.03e-06	6.46e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HPGDS—liver cancer	8.01e-06	6.45e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—liver cancer	8e-06	6.44e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.97e-06	6.42e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.96e-06	6.41e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NR1H4—liver cancer	7.91e-06	6.37e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.86e-06	6.33e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CRABP1—liver cancer	7.83e-06	6.31e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PSMA4—liver cancer	7.83e-06	6.31e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PSMD10—liver cancer	7.83e-06	6.31e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA3—liver cancer	7.78e-06	6.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.77e-06	6.26e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—liver cancer	7.72e-06	6.22e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PSMA4—liver cancer	7.65e-06	6.16e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PSMD10—liver cancer	7.65e-06	6.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GOT2—liver cancer	7.62e-06	6.14e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYCS—liver cancer	7.51e-06	6.05e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GOT2—liver cancer	7.44e-06	5.99e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GOT1—liver cancer	7.37e-06	5.94e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GGT1—liver cancer	7.37e-06	5.94e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	7.29e-06	5.87e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—liver cancer	7.28e-06	5.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.26e-06	5.84e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—liver cancer	7.22e-06	5.82e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PSMA4—liver cancer	7.21e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PSMD10—liver cancer	7.21e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2E1—liver cancer	7.16e-06	5.77e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.16e-06	5.77e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PSMA4—liver cancer	7.14e-06	5.75e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PSMD10—liver cancer	7.14e-06	5.75e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—liver cancer	7.12e-06	5.74e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA4—liver cancer	7.11e-06	5.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.05e-06	5.68e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CD—liver cancer	7.03e-06	5.66e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—liver cancer	7.02e-06	5.66e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GOT2—liver cancer	7.01e-06	5.65e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2E1—liver cancer	6.99e-06	5.63e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GOT2—liver cancer	6.95e-06	5.6e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—liver cancer	6.94e-06	5.59e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.94e-06	5.59e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA2—liver cancer	6.93e-06	5.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HPGDS—liver cancer	6.85e-06	5.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.81e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYCS—liver cancer	6.7e-06	5.4e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA1—liver cancer	6.69e-06	5.38e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—liver cancer	6.64e-06	5.34e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—liver cancer	6.62e-06	5.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NAT2—liver cancer	6.61e-06	5.32e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.59e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2E1—liver cancer	6.59e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GOT1—liver cancer	6.58e-06	5.3e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GGT1—liver cancer	6.58e-06	5.3e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYCS—liver cancer	6.54e-06	5.27e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2E1—liver cancer	6.53e-06	5.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—liver cancer	6.53e-06	5.26e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GGT1—liver cancer	6.42e-06	5.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GOT1—liver cancer	6.42e-06	5.17e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CD—liver cancer	6.4e-06	5.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDOB—liver cancer	6.34e-06	5.1e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.33e-06	5.09e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—liver cancer	6.32e-06	5.09e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.2e-06	4.99e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYCS—liver cancer	6.17e-06	4.97e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—liver cancer	6.13e-06	4.94e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.12e-06	4.93e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYCS—liver cancer	6.11e-06	4.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PSMD10—liver cancer	6.1e-06	4.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PSMA4—liver cancer	6.1e-06	4.92e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—liver cancer	6.08e-06	4.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GOT1—liver cancer	6.05e-06	4.87e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GGT1—liver cancer	6.05e-06	4.87e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CRABP1—liver cancer	6.05e-06	4.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GOT1—liver cancer	6e-06	4.83e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GGT1—liver cancer	6e-06	4.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GOT2—liver cancer	5.94e-06	4.78e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—liver cancer	5.91e-06	4.76e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—liver cancer	5.86e-06	4.72e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—liver cancer	5.86e-06	4.72e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—liver cancer	5.83e-06	4.69e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—liver cancer	5.77e-06	4.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—liver cancer	5.77e-06	4.64e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARA—liver cancer	5.75e-06	4.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—liver cancer	5.69e-06	4.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2E1—liver cancer	5.58e-06	4.5e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—liver cancer	5.58e-06	4.49e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—liver cancer	5.43e-06	4.38e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—liver cancer	5.43e-06	4.37e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.41e-06	4.35e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—liver cancer	5.39e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—liver cancer	5.38e-06	4.33e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—liver cancer	5.36e-06	4.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—liver cancer	5.31e-06	4.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—liver cancer	5.3e-06	4.27e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HPGDS—liver cancer	5.29e-06	4.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARA—liver cancer	5.27e-06	4.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYCS—liver cancer	5.22e-06	4.21e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.17e-06	4.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—liver cancer	5.15e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GGT1—liver cancer	5.13e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GOT1—liver cancer	5.13e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—liver cancer	5.07e-06	4.08e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—liver cancer	5.02e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—liver cancer	4.99e-06	4.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—liver cancer	4.95e-06	3.99e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—liver cancer	4.93e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—liver cancer	4.93e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—liver cancer	4.8e-06	3.86e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—liver cancer	4.79e-06	3.85e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—liver cancer	4.76e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.74e-06	3.82e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—liver cancer	4.73e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PSMA4—liver cancer	4.71e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PSMD10—liver cancer	4.71e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARA—liver cancer	4.71e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—liver cancer	4.69e-06	3.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—liver cancer	4.68e-06	3.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—liver cancer	4.6e-06	3.71e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARA—liver cancer	4.6e-06	3.7e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GOT2—liver cancer	4.58e-06	3.69e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—liver cancer	4.54e-06	3.66e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—liver cancer	4.52e-06	3.64e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—liver cancer	4.41e-06	3.55e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—liver cancer	4.38e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—liver cancer	4.36e-06	3.51e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—liver cancer	4.33e-06	3.49e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARA—liver cancer	4.33e-06	3.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2E1—liver cancer	4.31e-06	3.47e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARA—liver cancer	4.29e-06	3.46e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—liver cancer	4.28e-06	3.44e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—liver cancer	4.23e-06	3.41e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.23e-06	3.41e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—liver cancer	4.14e-06	3.34e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—liver cancer	4.03e-06	3.25e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYCS—liver cancer	4.03e-06	3.25e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—liver cancer	4.03e-06	3.24e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—liver cancer	4.01e-06	3.23e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—liver cancer	3.97e-06	3.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GOT1—liver cancer	3.96e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GGT1—liver cancer	3.96e-06	3.19e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—liver cancer	3.94e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—liver cancer	3.92e-06	3.16e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—liver cancer	3.89e-06	3.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.86e-06	3.11e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—liver cancer	3.8e-06	3.06e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—liver cancer	3.78e-06	3.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—liver cancer	3.74e-06	3.01e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—liver cancer	3.74e-06	3.01e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—liver cancer	3.71e-06	2.99e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—liver cancer	3.68e-06	2.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARA—liver cancer	3.67e-06	2.95e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—liver cancer	3.58e-06	2.88e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—liver cancer	3.55e-06	2.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—liver cancer	3.55e-06	2.86e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—liver cancer	3.54e-06	2.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—liver cancer	3.5e-06	2.82e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—liver cancer	3.5e-06	2.82e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—liver cancer	3.46e-06	2.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—liver cancer	3.46e-06	2.79e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—liver cancer	3.42e-06	2.75e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—liver cancer	3.4e-06	2.74e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.3e-06	2.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—liver cancer	3.27e-06	2.63e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—liver cancer	3.26e-06	2.63e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—liver cancer	3.23e-06	2.6e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—liver cancer	3.22e-06	2.59e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—liver cancer	3.19e-06	2.57e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—liver cancer	3.14e-06	2.53e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—liver cancer	3.1e-06	2.49e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—liver cancer	3.09e-06	2.49e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—liver cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—liver cancer	3.03e-06	2.44e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—liver cancer	3.02e-06	2.43e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—liver cancer	2.89e-06	2.32e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—liver cancer	2.84e-06	2.29e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARA—liver cancer	2.83e-06	2.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—liver cancer	2.82e-06	2.27e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—liver cancer	2.78e-06	2.24e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—liver cancer	2.76e-06	2.22e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—liver cancer	2.73e-06	2.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—liver cancer	2.42e-06	1.95e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—liver cancer	2.41e-06	1.94e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—liver cancer	2.34e-06	1.88e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—liver cancer	2.3e-06	1.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—liver cancer	2.13e-06	1.72e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—liver cancer	2.11e-06	1.7e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—liver cancer	2.1e-06	1.69e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—liver cancer	1.88e-06	1.52e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—liver cancer	1.88e-06	1.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—liver cancer	1.86e-06	1.5e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—liver cancer	1.84e-06	1.48e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—liver cancer	1.73e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—liver cancer	1.72e-06	1.39e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—liver cancer	1.72e-06	1.38e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—liver cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—liver cancer	1.5e-06	1.21e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—liver cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—liver cancer	1.42e-06	1.14e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—liver cancer	1.4e-06	1.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—liver cancer	1.2e-06	9.65e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—liver cancer	1.13e-06	9.12e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—liver cancer	9.25e-07	7.45e-06	CbGpPWpGaD
